HPLC Method for Simultaneous Quantitative Detection of Quercetin and Curcuminoids in Traditional Chinese Medicines

  • cc icon
  • ABSTRACT

    Objectives:

    Quercetin and curcuminoids are important bioactive compounds found in many herbs. Previously reported high performance liquid chromatography ultraviolet (HPLC-UV) methods for the detection of quercetin and curcuminoids have several disadvantages, including unsatisfactory separation times and lack of validation according the standard guidelines of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.

    Methods:

    A rapid, specific, reversed phase, HPLC-UV method with an isocratic elution of acetonitrile and 2% v/v acetic acid (40% : 60% v/v) (pH 2.6) at a flow rate of 1.3 mL/minutes, a column temperature of 35°C, and ultraviolet (UV) detection at 370 nm was developed. The method was validated and applied to the quantification of different types of market available Chinese medicine extracts, pills and tablets.

    Results:

    The method allowed simultaneous determination of quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin in the concentration ranges of 0.00488 ─ 200 μg/mL, 0.625 ─ 320 μg/mL, 0.07813 ─ 320 μg/mL and 0.03906 ─ 320 μg/mL, respectively. The limits of detection and quantification, respectively, were 0.00488 and 0.03906 μg/mL for quercetin, 0.62500 and 2.50000 μg/mL for bisdemethoxycurcumin, 0.07813 and 0.31250 μg/mL for demethoxycurcumin, and 0.03906 and 0.07813 μg/mL for curcumin. The percent relative intra day standard deviation (% RSD) values were 0.432 ─ 0.806 μg/mL, 0.576 ─ 0.723 μg/mL, 0.635 ─ 0.752 μg/mL and 0.655 ─ 0.732 μg/mL for quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin, respectively, and those for intra day precision were 0.323 ─ 0.968 μg/mL, 0.805 ─ 0.854 μg/mL, 0.078 ─ 0.844 μg/mL and 0.275 ─ 0.829 μg/mL, respectively. The intra day accuracies were 99.589% ─ 100.821%, 98.588% ─ 101.084%, 9.289% ─ 100.88%, and 98.292% ─ 101.022% for quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin, respectively, and the inter day accuracy were 99.665% ─ 103.06%, 97.669% ─ 103.513%, 99.569% ─ 103.617%, and 97.929% ─ 103.606%, respectively.

    Conclusion:

    The method was found to be simple, accurate and precise and is recommended for routine quality control analysis of commercial Chinese medicine products containing the flour flavonoids as their principle components in the extracts.


  • KEYWORD

    curcuminoid , high-performance liquid chromatography (HPLC) , international conference harmonisation (ICH) , quercetin

  • 1. Introduction

    Quercetin is a category in the class of flavonoids, and a sub class of flavonol. Flavonoids are plant polyphenolics found as pigments in fruits, vegetables, seeds, nuts, flowers, barks and leaves. It is also found in medicinal botanicals, such as Ginkgo biloba, Hypericum perforatum (St. John’s Wort), and Sambucum canadensis (El-der) [1]. The International Union of Pure and Applied Chemistry’s (IUPAC’s) name for quercetin is 3, 3’, 4’, 5, 7-pentahydroxyflavone (or its synonym 3, 3’, 4’, 5, 7-pentahydroxy-2-phenylchromen-4-one). Fig.1 shows the chemical structure of quercetin. The hydroxyl (-OH) groups attached at positions 3, 5, 7, 3’, and 4’ and the catechol B-ring produce the antioxidant properties of quercetin [2, 3]. The antioxidant and the free radical scavenging properties of quercetin have been reported to contribute to anti carcinogenic and anti inflammatory effects, and haves been extensively studied by researchers around the world [2].

    Extensive amounts of in vitro and in vivo animal research on quercetin’s pharmacological activities have been carried out, suggesting that quercetin might be used as a new therapeutic approach to decrease blood pressure [4], to inhibit fibronectin production by keloid derived fibroblasts [5], to inhibit neointimal hyperplasia in the abdominal aorta of rats [6], to treat gout [7], to inhibit asthmatic syndrome [8] and to promote dermal wound healing [9].

    Curcumin, commercially available in a mixture of curcumins (curcuminoids), contains ─ 77% pure curcumin, ─ 17% demethoxycurcumin and ─ 3% bisdemethoxycurcumin [10] (Fig 1). Curcuminoids are derived from Curcuma longa Linn, one of the most popular medicinal herbs, and are a polyphenolic. These compounds are yellow pigments and have been, commonly used as a dietary spices, natural coloring agents in foods, household medicines and insect repellents in South and Southeast Asia for thousands of years [11]. Curcumin and its synthetic derivatives (curcuminoids) show an array of pharmacological properties, such as antibacterial [12-14], antioxidant [13, 15-16], anti inflammatory [17, 18], anti tumor [19, 20] and anti proliferation [18, 21] properties. Curcumin/curcuminoids also possess potency as medicines for the treatment of diseases, including Alzheimer’s disease [22, 23], cancer [24, 25, 26], diabetes, gastric ulcers [27], malaria [28, 29] and for the treatment of wounds [30-32].

    A variety of methods for quantitatively detecting curcumin and quercetin contents have been reported. Among these, spectrophotometric methods are the most commonly used [33-36]. Thin layer chromatography (TLC) or column chromatography was usually used for separation of curcuminoids [37-39]. High performance liquid chromatography (HPLC) [40-45] and, high performance thin layer chromatography (HPTLC) [39, 46, 47] are the commonly used methods for quantitatively detecting the quercetin and curcuminoids contents. Some advanced methods have been developed for the analysis of curcuminoids contents, namely, ultra performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-qTOF-MS) [48], ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS) [49], high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) [50] and electrochemical-HPLC [51].

    For the above techniques, spectrophotometric methods are not available to quantify the individual curcuminoids due to the curcumin derivative’s being also absorbed at the same wavelength. Furthermore, LC-MS and/or qTOF are complicated and need expensive instrumentation. Even though HPTLC and TLC are widely used to study the fingerprints of plants, these methods are not suitable for analyzing compounds in combinations of herbs products like Chinese medicinal materials (because such products normally contain more than one herb). For simultaneous determination of quercetin and curcuminoids, HPLC method is the recommended technique because it uses separation, identification and quantification of the analytes from plant extracts, foods, pharmaceutical products, and body fluids.

    In the present study, a simple isocratic reversed phase HPLC method was developed according to international conference harmonisation (ICH) guidelines [52] for the simultaneous quantitative detection of quercetin and curcuminoids. The method was also validated by using market available traditional Chinese medicine materials such as granules, pills and tablets.

    2. Materials and Methods

    Curcumin (mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin) was obtained from Acros Organics, USA. Quercetin anhydrous was obtained from Sigma, USA. The HPLC grade acetonitrile and methanol were purchased from J.T. Baker, USA. Analytical grade acetic acid was obtained from QRëC, Malaysia. Nylon membrane filters 0.45 μm were purchased from Whatman, England.

    HPLC analysis was performed using a Shimadzu-LC system (Shimadzu, Japan) equipped with an CBM-20A controller, LC-20AT pump, DGU-20A5 prominence degasser, SIL-20A auto sampler, SPD-20AV detector and CTO-10ASvp column oven.

    Chromatographic separations were achieved using a Thermo Hypersil Gold column (250 mm × 4.6 mm I.D.: 5 μm). A security guard column (Zorbax Eclipse Plus) packed with a replaceable C-18 cartridge (12.5 mm × 4.6 mm ID.: 5 mm) was used to protect the analytical column. A reverse phase HPLC assay was carried out using an isocratic elution with a flow rate of 1.3 mL/minutes, a column temperature of 35°C, a mobile phase of acetonitrile and 2% v/v acetic acid (pH 2.60) (40% : 60% v/v) and a detection wavelength of 370 nm. The injection volume was 20 μL of each solutions. The total run time was 18.5 minutes for each injection. Data were acquired and processed with LC-Solution Software. Solvents and distilled water were prior filtered through a 0.45-μm nylon membrane by using a set of glass bottles with the aid of a vacuum pump (Fisherbrand FB 70155, Fisher Scientific, UK).

    Twenty mg of a mixture of curcumin (containing mainly curcumin, demethoxycurcumin and bisdemethoxycurcumin) and 20 mg of quercetin were accurately weighed using a microbalance (Sartorius, MC5, Germany) and dissolved in 20 mL of HPLC grade methanol in a 20 mL volumetric flask. The mixtures were diluted to 320 μg/mL with HPLC grade methanol; and were then serially doubling diluted to 1.22 ng/mL. These solutions were used as calibration standards for the quantitative determinations of the limit of detection (LOD), the limit of quantification (LOQ) and yhe limit of linearity (LOL), and for the linear range analysis. Three quality control (QC) samples at concentrations of 3.75 μg/mL, 100 μg/mL and 160 μg/mL, respectively, were prepared from the stock solution. All solutions were stored in tightened screw cap bottles to avoid evaporation and were protected from light, and were kept in a refrigerator (4°C) for not more than two weeks.

    Standard solutions with concentrations in the range from of 1.22 ng/mL to 320 μg/mL were injected in duplicate into the HPLC unit. The LOD and LOQ of quercetin (QUE), bisdemethoxycurcumin (BDMC), demethoxycurcumin (DMC) and curcumin (CUR) were determined in a at the lower concentration range based on the signal to-noise ratio. According to The United Sates Pharmacopeia (USP), the LOD and the LOQ are in terms of 2 or 3 times, and 10 times the noise level respectively. The LOL was determined by plotting a calibration curve (mean value of the peak areas against the concentrations) beginnings with the LOQ concentration and proceeding to the data point that deviated from the regression line. The coefficient of determination (R2 ≥ 0.999) was used as a guideline to evaluate the model fit of a regression equation.

    Linear ranges for quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin included concentrations of 1.25, 5, 20, 40, 80, 140 and 200 μg/mL. Separate calibration curves were constructed for quercetin, bisdemethoxycurcumin demethoxycurcumin and curcumin by plotting the peak areas against the concentrations, and the methods were evaluated by determining the coefficient of determination (R2). Unknown assay samples were quantified by referencing them to these calibration curves.

    QC samples (3.75, 100 and 160 μg/mL) were used to validate intra day and inter day accuracies and precisions. Intra day precisions and accuracies were determined by using a replicate analysis (n = 6) of the QC samples on the same day under the same analytical conditions. Inter day precisions and accuracies were tested by using a replicate analysis (n = 3) of the same QC samples on six consecutive days. The precision is calculated from the mean of the accuracy and the relative standard deviation (RSD). Accuracy is a measure of how close the experimental value to the true value, and is expressed as a percent. The experimental value was calculated from the calibration curve by using the linear regression equation, y = mx + c. The constant m is the slope of the curve. The constant c is the y intercept and can be determined by extrapolating the straight line to the y axis.

    Four variation parameters of robustness were studied: change in organic composition by ± 2.0% (Table 4a) , change in acetic acid concentration by ± 1.0% v/v (effect of buffer pH) (Table 4b), change in the flow rate of ± 0.1 mL/min (Table 4c) and change in the column temperature of ± 5.0°C (Table 4d). The retention time, peak area, resolution, tailing factor, theoretical plate number and capacity factor values obtained from the variation parameters were compared to those obtained for the normal method conditions. The differences were analyzed by using SPSS version 20, and a one way analysis of variance (ANOVA), followed by Tukey’s test. P-values < 0.05 were considered significant.

    The system suitability parameters were assessed by using six replicate analysis of the QC sample at 160 μg/mL. The acceptance criteria were in accordance with the guidelines of the Centre for Drug Evaluation and Research [53].

    The method developed in this study was used to quantitatively determination the quercetin and the curcuminoid contents of extracts, pills and tablets made from Chinese medicinal plants.

    3. Results

    The LOD and the LOQ were determined based on the signal to noise (S/N) ratio, with the S/N > 3 and the S/N > 10 for the LOD and the LOQ, respectively. The LODs of quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin were 0.00488, 0.62500, 0.07813 and 0.03906 μg/mL, respectively. The LOQs of quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin were 0.03906, 2.5000, 0.31250 and 0.07813 μg/mL, respectively (Table 1) The linearity for detecting quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin was tested against a mixture of calibration standards with concentration ranging from 1.22 ng/mL to 320 μg/mL. The LOL of each compound was determined from a separate calibration curve. Quercetin was linear up to 200 μg/mL, while bisdemethoxycurcumin, demethoxycurcumin and curcumin were linear up to 320 μg/mL.

    Linear calibration curves in the range from 1.25 to 200 μg/ mL were constructed for each compound by plotting the peak area against the concentration. The retention times and the peak areas are tabulated in (Table 2) The values of R2, the y-intercept and the slope for each compound’s calibration plot are shown in (Table 1) A regression analysis of the data showed a linear relationship for quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin, with excellent R2 values of 0.99993, 0.99984, 0.99985 and 0.99993 μg/mL, respectively.

    The peaks of quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin were well separated at different retention times with resolutions of 32.195, 2.887 and 2.830 for quercetin-bisdemethoxycurcumin, bisdemethoxycurcumin-demethoxycurcumin and demethoxycurcumin-curcumin, respectively. No interferences or excipient peaks co eluted with the analytes were observed, indicating the method is selective and specific in relation to the medium and excipients used in this study (Fig 2), (Table 2).

    Precision and accuracy data for the intraday and the inter-day variations for the three QC samples are summarized in (Table 3). The RSD values for the intraday and the inter day precisions were < 1%. For the accuracy test, the intraday and the inter day accuracies ranges from 98.292% to 103.617%, confirming the accuracy of the method.

    Robustness is a measure of the method’s capability to remain unaffected by small, but deliberate, variations in the method parameters [52]. The robustness parameters tested were the mobile phase’s composition, the concentration of acetic acid (pH effect), the flow rate and the column temperature. The results are tabulated in Table 4(a-d). The retention times for all four compounds due to variations in the parameters were significantly different compared to those for the normal parameters. The peak area for curcumin was not significantly different after changing the acetic acid concentration from 2% to 3%, but was significantly different after changing the concentration from 2% to 1%. Quercetin, bisdemethoxycurcumin and demethoxycurcumin were shown to have significant differences in their peak area when the concentration of acetic acid was changed. Changes in the acetonitrile’s composition and temperature were shown not to cause significant differences in quecetin’s peak areas, however significant differences were seen in curcumin, bisdemethoxycurcumin and demethoxycurcumin peak areas. Increasing or decreasing the flow rate by 0.1 mL/min from normal conditions significantly raised or reduced the values of the peak areas of quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin. Although changes in experimental conditions changed the retention time, the peak area and the values of the system’s suitability parameters, the four analyzed peaks were still well resolved from each other and from additional small peaks and showed good resolution in the tested parameters (Fig 3)

    The system suitability criteria were in accordance with the Centre for Drug Evaluation and Research (CDER) guidelines [53] and are summarized in (Table 5) The mean values of the six replicate injections of 160 μg/mL QC standards were used to evaluate the retention time, the peak area, the resolutions for the analyte peaks, the tailing factor, the number of theoretical plates and the capacity factor. The results for the system suitability parameters are shown in (Table 6) The RSD values for the tested parameters were < 1%, indicating the precision of the method. The tested parameters passed the criteria under the CDER guidelines except for the capacity factor value for quercetin (< 2) [53]. This is because the retention time of quercetin was quite fast and just 1 minute behind the solvent peak. However, the quercetin peak was well resolved from the solvent peak and from the front additional small peak.

    The proposed method was applied to quantitatively detect the quercetin and curcuminoids in Chinese medicines such as plant granule extracts, tablets and pills. The results of 19 samples are summarized in (Table 7). In the tested samples, BDMC had the highest concentration compared to the other two curcuminoids tested (DMC and CUR), and was found in the formulations of granule extracts, tablets and pills (such as samples 12, 13, 15, 16, 18 and 19) (Table 7). The preference of BDMC over CUR in the medicine might be due to its strong biological properties, which its use as a cure for diseases or as a supplement for certain purposes. Quercetin was found in most of the tested samples, indicating that this compound is common and useful for treatment. (Fig 4) shows the chromatograms for the quercetin and the curcuminoids found in the tested samples.

    4. Discussion

    The HPLC method was developed by optimization of the mobile phase conditions so that quercetin, bisdemethoxycurcumin, demethoxycurcumin and curcumin peaks could be simultaneously detected by using the same solvent system and an isocratic method. The flow rate, acetic acid concentration and column temperature were varied to determine the chromatographic conditions giving the best separation and the shortest analysis time. UV visible sperctrophotometry in the wavelength from 200 to 500 nm was used for the detection of quercetin and curcuminoids; 370 nm was chosen as appropriate wavelength for the analysis of quercetin and curcumin derivatives.

    The retention times for quercetin (3.97 minutes), bisdemethoxycurcumin (13.84 minutes), demethoxycurcumin (15.23 minutes) and curcumin (16.72 minutes) were reasonable because the method is simple and general. The chromatograph peaks for mixtures of curcumin were identified based on their percentages in the mixtures. Most of the commercially available curcumin/turmeric products contain mixtures of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Among these, curcumin (46% ─ 72%) is the major compound, followed by demethoxycurcumin (11% ─ 28%) and bisdemethoxycurcumin (3% ─ 14%). All four analyte peaks were well separated from each other and from small additional peaks.

    The linear ranges of quercetin (0.039 ─ 200 μg/mL), bisdemethoxycurcumin (2.500 ─ 320 μg/mL), demethoxycurcumin (0.313 ─ 320 μg/mL) and curcumin (0.078 ─ 320 μg/mL) are suitable for the analysis of most the pharmaceutical products, containing the compounds and for the analysis of crude herbs. The low LOD and LOQ values indicate that the method provides adequate sensitivity. The R2 values > 0.999 for the regression model for the calibration curves confirm the good linearity of the method.

    The accuracies ranged from 98.292% ─ 103.617%, and the precisions were less than 1% which indicate that the proposed method is well validated and suitable for quantitatively detecting curcuminoids and quercetin simultaneously in pharmaceutical products, herb materials and various turmeric and quercetin containing products.

    System suitability testing is important to ensure the performance of the system before and during the analysis. As defined in the United States Pharmacopeia/National Formulary (USP/NF) [54] system suitability parameters were established as a direct result of the ruggedness and the robustness of the experiments. The system suitability testing proved that the proposed method will allow the separation of all four anaytes and will produce satisfactory peak shapes.

    5. Conclusion

    A simple isocratic RP-HPLC method with UV detection has been developed for simultaneous detection of quercetin, curcumin, demethoxycurcumin and bisdemethoxycurcumin. The analytes were well separated and detected within 19 minutes. This method was validated for specificity, linearity, precision, accuracy and robustness as per ICH guidelines. The data showed good selectivity and sensitivity, a wide linear range, precision and accuracy. The method was sensitive to HPLC conditions; that is, changes in the mobile phase’s composition, the pH, the column temperature and the flow rate affected the retention time and response, but did not affected the separation of the compounds. In addition, each parameter showed good repeatability of the retention time and response. In conclusion, the proposed method is simple, easy and cost effective, no specific solvent is involved and it utilizes common HPLC instruments with UV detectors. Hence, this UV-HPLC method is suitable for routine analysis of quercetin and curcuminoid formulations or products.

  • 1. Kelly GS 1998 Quercetin [Altern Med Rev] Vol.3 P.140-143 google
  • 2. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC 2007 A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/ carcinogenic properties [Food Chem Toxicol] Vol.45 P.2179-2205 google doi
  • 3. Materska M 2008 Quercetin and its derivatives: chemical structure and bioactivity - a review [Pol J Food Nutr Sci] Vol.58 P.407-413 google
  • 4. Larson AJ, Symons JD, Jalili T 2012 Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms [Am Soc Nutrition] Vol.3 P.39-46 google doi
  • 5. Phan TT, Lim IJ, Sun L, Chan SY, Bay BH, Tan EK 2003 Quercetin inhibits fibronectin production by keloid- derived fibroblasts. implication for the treatment of excessive scars [J Dermatol Sci] Vol.33 P.192-194 google doi
  • 6. Huang BF, Wang W, Fu YC, Zhou XH, Wang X 2009 The effect of quercetin on neointima formation in a rat artery ballon injury model [Pathol Res Pract] Vol.205 P.515-523 google doi
  • 7. Zhu JX, Wang Y, Kong LD, Yang C, Zhang X 2004 Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate- induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver [J Ethnopharmacol] Vol.93 P.133-140 google doi
  • 8. Park HJ, Lee CM, Jung ID, Lee JS, Jeong YI, Chang JH 2009 Quercetin regulates Th1/Th2 balance in a murine model of asthma [Int Immunopharmacol] Vol.9 P.261-267 google doi
  • 9. Gomathi K, Gopinath D, Ahmed MR, Jayakumar R 2003 Quercetin incorporated collagen matrices for dermal wound healing processes in rat [Biomaterials] Vol.24 P.2767-2772 google doi
  • 10. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G 2007 Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism [Carcinogenesis] Vol.28 P.1765-1773 google
  • 11. Pothitirat W, Gritsanapan W 2005 Quantitative analysis of curcumin, demethoxycurcumin and bisdemethoxycurcumin in the crude curcuminoid extract from curcuma longa in Thailand by TLC-densitometry [Warasan Phesatchasat] Vol.32 P.23-30 google
  • 12. Bhawana RK, Buttar HS, Jain VK, Jain N 2011 Curcumin nanoparticles: preparation, characterization and antimicrobial study [J Agric Food Chem] Vol.59 P.2056-2061 google doi
  • 13. Parvathy KS, Negi PS, Srinivas P 2009 Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside [Food Chem] Vol.115 P.265-271 google
  • 14. Wang Y, Lu Z, Wu H, Lv F 2009 Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens [Int J Food Microbiol] Vol.136 P.71-74 google doi
  • 15. Barzegar A 2012 The role of electron-transfer and H-atom donation on the superb antioxidant activity and free radical reaction of curcumin [Food Chem] Vol.135 P.1369-1376 google
  • 16. Grinberg LN, Shalev O, Tønnesen HH, Rachmilewitz EA 1996 Studies on curcumin and curcuminoids: XXVI. Antioxidant effects of curcumin on the red blood cell membrane [Int J Pharm] Vol.132 P.251-257 google doi
  • 17. Khan MA, El-Khatib R, Rainsford KD, Whitehouse MW 2012 Synthesis and anti-inflammatory properties of some aromatic and heterocyclic aromatic curcuminoids [Bioorg Chem] Vol.40 P.30-38 google
  • 18. Ravindran J, Subbaraju GV, Ramani MV, Sung B, Aggarwal BB 2010 Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro [Biochemical Pharmacology] Vol.79 P.1658-1666 google doi
  • 19. Anto RJ, Kuttan G, Babu KVD, Rajasekharan KN, Kuttan R 1996 Anti-tumour and free radical scavenging activity of synthetic curcuminoids [Int J Pharm] Vol.131 P.1-7 google doi
  • 20. Ruby AJ, Kuttan G, Babu D, Rajasekharan KN, Kuttan R 1995 Anti-tumour and antioxidant activity of natural curcuminoids [Cancer Letter] Vol.94 P.79-83 google doi
  • 21. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S, Delage C 1998 Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationship [Cancer Letters] Vol.129 P.111-116 google doi
  • 22. Ahmed T, Gilani AH 2009 Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine- induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease [Pharmacol Biochem Behav] Vol.91 P.554-559 google
  • 23. Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY 2012 Curcuminoids and resveratrol as anti-Alzheimer agents [Taiwan J Obstet Gynecol] Vol.51 P.515-525 google doi
  • 24. Kunnumakkara AB, Anand P, Aggarwal BB 2008 Curcumin inhibits proliferation, invasion, angiogenisis and metastasis of different cancers through interaction with multiple cell signaling proteins [Cancer Letters] Vol.269 P.199-225 google doi
  • 25. Shoji M, Nakagawa K, Watanabe A, Tsuduki T, Yamada T, Kuwahara S 2014 Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells [Food Chem] Vol.151 P.126-132 google doi
  • 26. Kim T, Davis J, Zhang AJ, He X, Mathews ST 2009 Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells [Biochem Biophys Res Commun] Vol.388 P.377-382 google doi
  • 27. Mahattanadul S, Nakamura T, Panichayupakaranant P, Phdoongsombut N, Tungsinmunkong K, Bouking P 2009 Comparative antiulcer effect of bisdemethoxycurcumin and curcumin in a gastric ulcer model system [Phytomedicine] Vol.16 P.342-351 google doi
  • 28. Jain K, Sood S, Gowthamarajan K 2013 Modulation of cerebral malaria by curcumin as an adjunctive therapy [Braz J Infect Dis] Vol.17 P.579-591 google doi
  • 29. Nayak A, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB 2010 Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment [Colloids Surf B Biointerfaces] Vol.81 P.263-273 google doi
  • 30. Jagetia GC, Rajanikant GK 2004 Role of curcumin, a naturally occurring phenolic compound of turmeric in accelerating the repair of excision wound, in mice wholebody exposed to various doses of γ-radiation [J Surg Res] Vol.120 P.127-138 google
  • 31. Li X, Nan K, Li L, Zhang Z, Chen H 2012 In vivo evaluation of curcumin nanoformulation loaded methoxy poly(ethyleneglycol)- graft-chitosan composite film for wound healing application [Carbohydr Polym] Vol.88 P.84-90 google
  • 32. Panchatcharam M, Miriyala S, Gayathri VS, Suguna L 2006 Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species [Mol Cell Biochem] Vol.290 P.87-96 google doi
  • 33. Aneja G, Dave U, Vadodaria K 2012 Simultaneous estimation of piperine, quercetin, and curcumin in a mixture using u.v-visible spectrophotometer and method validation [International Journal of Therapeutic Applications] Vol.8 P.14-17 google
  • 34. Askal HF, Saleh GA, Backheet EY 1992 A selective spectrophotometric method for determination of quercetin in the presence of other flavonoids [Talanta] Vol.39 P.259-263 google doi
  • 35. Kunti? V, Peji? N, Mi?i? S, Vukojevi? V, Vuji? Z, Male?ev D 2005 Determination of quercetin in pharmaceutical formations via its reaction with potassium titanyloxalate. Determination of the stability constants of the quercetin titanyloxalato complex [J Serb Chem Soc] Vol.70 P.753-763 google
  • 36. Sharma K, Agrawal SS, Gupta M 2012 Development and validation of UV spectrophotometric method for the estimation of curucmin in bulk drug and pharmaceutical dosage forms [IJDDR] Vol.4 P.375-380 google
  • 37. Kulkarni SJ, Maske KN, Budre MP, Mahajan RP 2012 Extraction and purification of curcuminoids from Turmeric (curcuma longa L.) [Int J Pharm Technol] Vol.1 P.81-84 google
  • 38. Revathy S, Elumalai S, Benny M, Antony B:, purification and 2011 ) by column chromatography [Journal of Experimental Sciences] Vol.2 P.21-25 google
  • 39. Sheikh S, Asghar S, Ahmad S 2013 Development of HPTLC method and its validation for the estimation of curcuminoids from polyherbal mouth ulcer gel formulation [IOSR J Pharm Biol Sci] Vol.3 P.29-34 google doi
  • 40. Careri M, Corradini C, Elviri L, Nicoletti I, Zagnoni I 2003 Direct HPLC analysis of quercetin and trans-resveratrol in red wine, grape, and winemaking byproducts [J Agric Food Chem] Vol.51 P.5226-5231 google
  • 41. Ishii K, Furuta T, Kasuya Y 2003 High-performance liquid chromatographic determination of quercetin in human plasma and urine utilizing solid-phase extraction and ultraviolet detection [J Chromatogr B] Vol.794 P.49-56 google doi
  • 42. Jayaprakasha GK, Rao LJM, Sakariah KK 2002 Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin [J Agric Food Chem] Vol.50 P.3668-3672 google doi
  • 43. Rajalakshmi PV, Senthil KK 2009 Direct HPLC analysis of quercetin in exudates of abutilon indicum (Linn). malvaceae [J Pharm Sci Technol] Vol.1 P.80-83 google
  • 44. Wichitnithad W, Jongaroonngamsang N, Pummangura S 2009 A simple isocratic HPLC method for the simultaneous determination of curcuminoids in commercial turmeric extracts [Phytochem Anal] Vol.20 P.314-319 google doi
  • 45. Zhang J, Jinnai S, Ikeda R, Wada M, Hayashida S, Nakashima K 2009 A simple HPLC-fluorescence method for quantitation of curcuminoids and its application to turmeric products [Analyt Sci] Vol.25 P.385-388 google doi
  • 46. Ashraf K, Mujeeg M, Ahmad A, Amir M, Mallick MN, Sharma D 2012 Validated HPTLC analysis method for quantification of variability in content of curcumin in Curcuma long L (turmeric) collected from different geographical region of India [Asian Pac J Trop Biomed] P.S584-S588 google
  • 47. Paramasivam M, Poi R, Banerjee H, Bandyopadhyay A 2009 High-performance thin layer chromatographic method for quantitative determination of curcuminoids in Curcuma longa germplasm [Food Chem] Vol.113 P.640-644 google doi
  • 48. Verma MK, Najar IA, Tikoo MK, Singh G, Gupta DK, Anand R 2013 Development of a validated UPLCqTOF- MS method for the determination of curcuminoids and their pharmacokinetic study in mice [DARU Journal of Pharmaceutical Sciences] Vol.21 P.11 google
  • 49. Avula B, Wang YH, Khan IA 2012 Quantitative determination of curcuminoids from the roots of Curcuma longa, Curcuma species and dietary supplements using an UPLC-UV-MS method [J Chromatograph Separat Techniq] Vol.3 P.1000120 google
  • 50. Li W, Xiao H, Wang L, Liang X 2009 Analysis of minor curcuminoids in Curcuma longa L. by high performance liquid chromatography-tandem mass spectrometry [Se Pu] Vol.27 P.264-269 google
  • 51. Long Y, Zhang W, Wang F, Chen Z 2014 Simultaneous determination of three curcuminoids in Curcuma long L. by high performance liquid chromatography coupled with electrochemical detection [J Pharm Anal] Vol.4 P.325-330 google
  • 52. 1996 Validation of analytical procedures: text and methodology Q2 (R1). ICH Harmonised Tripartite Guideline [internet]. google
  • 53. 1994 Reviewer guidance-validation of chromatographic methods [internet]. google
  • 54. 2008 General chapters <621> Chromatography Glossary of Symbols [internet]. google
  • [Fig. 1] Chemical structures of quercetin, and the curcuminoids: curcumin, demethoxycurcumin and bisdemethoxycurcumin.
    Chemical structures of quercetin, and the curcuminoids: curcumin, demethoxycurcumin and bisdemethoxycurcumin.
  • [Table. 1] LOD, LOQ, LOL and linear regression analysis parameters for QUE, BDMC, DMC and CUR
    LOD, LOQ, LOL and linear regression analysis parameters for QUE, BDMC, DMC and CUR
  • [Fig. 2] Chromatograms of quercetin and curcuminoids. QUE, quercetin; BDMC, bisdemethoxycurcumin; DMC, demethoxycurcumin; CUR, curcumin.
    Chromatograms of quercetin and curcuminoids. QUE, quercetin; BDMC, bisdemethoxycurcumin; DMC, demethoxycurcumin; CUR, curcumin.
  • [Table. 2] Retention times and responses data for calibration standards of QUE, BDMC, DMC, and CUR
    Retention times and responses data for calibration standards of QUE, BDMC, DMC, and CUR
  • [Table. 3] Precisions and accuracies for intraday and interday repetitions for the quantitative detection of QUE, BDMC, DMC and CUR
    Precisions and accuracies for intraday and interday repetitions for the quantitative detection of QUE, BDMC, DMC and CUR
  • [Table. 4a] (a). Robustness ? change in organic composition
    (a). Robustness ? change in organic composition
  • [Table. 4b] (b). Robustness ? change in acetic acid concentration
    (b). Robustness ? change in acetic acid concentration
  • [Table. 4c] (c). Robustness ? change in flow rate
    (c). Robustness ? change in flow rate
  • [Table. 4d] (d). Robustness ? change in column temperature
    (d). Robustness ? change in column temperature
  • [Table. 5] System suitability parameters, calculation formula and recommendations
    System suitability parameters, calculation formula and recommendations
  • [Table. 6] System suitability testing
    System suitability testing
  • [Fig. 3] Combined chromatograms of quercetin (QUE), bisdemethoxycurcumin (BMDC), demethoxycurcumin (DMC), curcumin (CUR) analyzed at different conditions: (a) acetonitrile: 2% acetic acid at a flow rate of 1.3 mL/minutes, 35°C (b) acetonitrile: different acetic acid concentrations (40% : 60% v/v) at a flow rate of 1.3 mL/min, 35°C (c) acetonitrile: 2% acetic acid (40% : 60% v/v) at different flow rates, 35°C (d) acetonitrile: 2% acetic acid (40% : 60% v/v) at a flow rate of 1.3 mL/min at different temperatures.
    Combined chromatograms of quercetin (QUE), bisdemethoxycurcumin (BMDC), demethoxycurcumin (DMC), curcumin (CUR) analyzed at different conditions: (a) acetonitrile: 2% acetic acid at a flow rate of 1.3 mL/minutes, 35°C (b) acetonitrile: different acetic acid concentrations (40% : 60% v/v) at a flow rate of 1.3 mL/min, 35°C (c) acetonitrile: 2% acetic acid (40% : 60% v/v) at different flow rates, 35°C (d) acetonitrile: 2% acetic acid (40% : 60% v/v) at a flow rate of 1.3 mL/min at different temperatures.
  • [Table. 7] Concentration of QUE, CUR, DMS and BDMC in Chinese medicines
    Concentration of QUE, CUR, DMS and BDMC in Chinese medicines
  • [Fig. 4] Chromatograms for Chinese medicinal plant extracts (a) containing quercetin and (b) containing curcuminoids. QUE, quercetin; BDMC, bisdemethoxycurcumin; DMC, demethoxycurcumin; CUR, curcumin.
    Chromatograms for Chinese medicinal plant extracts (a) containing quercetin and (b) containing curcuminoids. QUE, quercetin; BDMC, bisdemethoxycurcumin; DMC, demethoxycurcumin; CUR, curcumin.